Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.

Ítems similars

• FEIBA in haemophiliacs with factor VIII inhibitor.
  per: Thomas, T, et al.
  Publicat: (1977)
• Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
  per: Wójcik, Cezary, et al.
  Publicat: (2009)
• Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients
  per: Rampersad, A. G., et al.
  Publicat: (2018)
• Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
  per: Tjønnfjord, Geir E, et al.
  Publicat: (2007)
• Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial
  per: Sera, Valerie A., et al.
  Publicat: (2021)